Table 3 Cumulative cost effectiveness/savings after 5, 10, 25, and 50Â years of vaccination program. Cost savings is achieved within 6Â years considering indirect costs and within 8Â years if indirect costs are excluded. Values are for the entire population
Cumulative outcomes | Universal Vaccination | |||
|---|---|---|---|---|
5 y | 10 y | 25 y | 50 y | |
QALY’s Gaineda | 4800 | 10,521 | 24,144 | 37,502 |
Vaccination Cost (millions) | $9.40 | $17.52 | $35.76 | $52.83 |
Disease Cost Avoided (millions) | $8.06 | $18.60 | $47.78 | $81.41 |
Indirect cost avoided (millions) | $0.99 | $2.61 | $8.00 | $14.03 |
Total Cost Savings(millions, including indirect costs) | – | $3.69 | $20.03 | $42.60 |
Total Cost Savings(millions, excluding indirect cost) | – | $1.09 | $12.02 | $28.57 |
ICERb ($/QALY, including indirect costs) | 75 | Cost saving | Cost saving | Cost saving |
ICER ($/QALY, excluding indirect cost) | 281 | Cost saving | Cost saving | Cost saving |